These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9385468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of aging and antihypertensive treatment on aortic internal diameter in spontaneously hypertensive rats.
    Giummelly P, Lartaud-Idjouadiene I, Marque V, Niederhoffer N, Chillon JM, Capdeville-Atkinson C, Atkinson J.
    Hypertension; 1999 Aug; 34(2):207-11. PubMed ID: 10454442
    [Abstract] [Full Text] [Related]

  • 3. Withdrawal reveals lack of effect of prolonged antihypertensive treatment on intrinsic aortic wall stiffness in senescent spontaneously hypertensive rats.
    Marque V, Grima M, Kieffer P, Capdeville-Atkinson C, Atkinson J, Lartaud-Idjouadiene I.
    Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):898-904. PubMed ID: 12207569
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms responsible for sustained hypotension after captopril treatment.
    Chen DG, Jin XQ, Wang HJ, Chen SC.
    J Hypertens; 1995 Oct; 13(10):1113-21. PubMed ID: 8586803
    [Abstract] [Full Text] [Related]

  • 5. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E, Hollenberg NK.
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [Abstract] [Full Text] [Related]

  • 6. Interaction between lifetime captopril treatment and NaCI-sensitive hypertension in spontaneously hypertensive rats and Wistar-Kyoto rats.
    Fang Z, Sripairojthikoon W, Calhoun DA, Zhu S, Berecek KH, Wyss JM.
    J Hypertens; 1999 Jul; 17(7):983-91. PubMed ID: 10419072
    [Abstract] [Full Text] [Related]

  • 7. Captopril improves cerebrovascular structure and function in old hypertensive rats.
    Dupuis F, Atkinson J, Limiñana P, Chillon JM.
    Br J Pharmacol; 2005 Feb; 144(3):349-56. PubMed ID: 15655534
    [Abstract] [Full Text] [Related]

  • 8. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat.
    Brooks WW, Bing OH, Robinson KG, Slawsky MT, Chaletsky DM, Conrad CH.
    Circulation; 1997 Dec 02; 96(11):4002-10. PubMed ID: 9403625
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
    Castro-Moreno P, Pardo JP, Hernández-Muñoz R, López-Guerrero JJ, Del Valle-Mondragón L, Pastelín-Hernández G, Ibarra-Barajas M, Villalobos-Molina R.
    Auton Autacoid Pharmacol; 2012 Oct 02; 32(3 Pt 4):61-9. PubMed ID: 22994939
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Captopril treatment and its withdrawal prevents impairment of endothelium-dependent responses in the spontaneously hypertensive rat.
    Keaton AK, White CR, Berecek KH.
    Clin Exp Hypertens; 1998 Nov 02; 20(8):847-66. PubMed ID: 9817606
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
    Januszewicz A, Lapiński M, Styś T, Styś A, Loń S.
    Pol J Pharmacol; 1994 Nov 02; 46(3):153-61. PubMed ID: 8000447
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of early perturbation of the renin-angiotensin system on cardiovascular remodeling in spontaneously hypertensive rats.
    Berecek KH, Reaves P, Raizada M.
    Vascul Pharmacol; 2005 Feb 02; 42(3):93-8. PubMed ID: 15792926
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention of nephrosclerosis and cardiac hypertrophy by captopril treatment of spontaneously hypertensive rats.
    Ohashi H, Matsunaga M, Yoshida H, Nagai H, Pak CH, Hara A, Kawai C.
    Jpn Circ J; 1986 Feb 02; 50(2):140-6. PubMed ID: 2941600
    [Abstract] [Full Text] [Related]

  • 18. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
    Christensen KL, Jespersen LT, Mulvany MJ.
    J Hypertens; 1989 Feb 02; 7(2):83-90. PubMed ID: 2522478
    [Abstract] [Full Text] [Related]

  • 19. Year-long antihypertensive therapy with candesartan completely prevents development of cardiovascular organ injuries in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohno E, Furukata S, Sudo Y, Nakano N, Takahashi T, Ono H, Matsuoka H.
    Int Heart J; 2010 Feb 02; 51(5):359-64. PubMed ID: 20966610
    [Abstract] [Full Text] [Related]

  • 20. Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.
    Demirci B, McKeown PP, Bayraktutan U.
    J Hypertens; 2005 Dec 02; 23(12):2219-27. PubMed ID: 16269964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.